Literature DB >> 20579278

Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.

B Bürgel1, M Friesland, A Koch, M P Manns, H Wedemeyer, K Weissenborn, W J Schulz-Schaeffer, T Pietschmann, E Steinmann, S Ciesek.   

Abstract

Patients with chronic hepatitis C virus (HCV) infection show an increased incidence of nervous system disorders such as chronic fatigue syndrome, depression and cognitive dysfunction. It is unclear whether this is because of HCV replication in the brain and in peripheral neuronal cells or to more indirect effects of HCV infection on the central or peripheral nervous system. The aim of this study was to investigate whether cells originating from these tissues are permissive for HCV cell entry, RNA replication and virus assembly. Among eight cell lines analysed, the human peripheral neuroblastoma cell line SKNMC expressed all HCV entry factors and was efficiently infected with HCV pseudoparticles (HCVpp) independent of the HCV genotype. All remaining cell types including human neuroblastoma and glioblastoma cell lines and microglial cells lacked expression of at least one host factor essential for HCV entry. When transfected with HCV luciferase reporter virus RNA, inoculated with HCV reporter viruses or challenged with high-titre cell culture-derived HCV, none of these cells supported detectable HCV RNA replication. Thus, in conclusion, this comprehensive screening did not reveal evidence directly strengthening the notion that HCV enters and replicates in the central nervous system. However, productive viral entry into the peripheral neuroblastoma cell line SKNMC indicates that HCV may penetrate into certain nonhepatic cell types which may serve as viral reservoirs and could modulate viral pathogenesis.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579278     DOI: 10.1111/j.1365-2893.2010.01339.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

1.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  Hepatitis C virus host cell entry.

Authors:  Alexander Ploss; Matthew J Evans
Journal:  Curr Opin Virol       Date:  2012-01-04       Impact factor: 7.090

3.  Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.

Authors:  Qiang Ding; Markus von Schaewen; Gabriela Hrebikova; Brigitte Heller; Lisa Sandmann; Mario Plaas; Alexander Ploss
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 4.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

5.  Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines.

Authors:  Anne Frentzen; Kathrin Hüging; Julia Bitzegeio; Martina Friesland; Sibylle Haid; Juliane Gentzsch; Markus Hoffmann; Dirk Lindemann; Gert Zimmer; Florian Zielecki; Friedemann Weber; Eike Steinmann; Thomas Pietschmann
Journal:  PLoS Pathog       Date:  2011-04-28       Impact factor: 6.823

6.  Host cell mTORC1 is required for HCV RNA replication.

Authors:  Stefanie Stöhr; Rui Costa; Lisa Sandmann; Sandra Westhaus; Stephanie Pfaender; Eva Dazert; Philip Meuleman; Florian W R Vondran; Michael P Manns; Eike Steinmann; Thomas von Hahn; Sandra Ciesek
Journal:  Gut       Date:  2015-08-14       Impact factor: 23.059

7.  Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.

Authors:  Lynda Aoudjehane; Grégoire Bisch; Olivier Scatton; Christelle Granier; Jesintha Gaston; Chantal Housset; Philippe Roingeard; François-Loïc Cosset; Fabiano Perdigao; Pierre Balladur; Takaji Wakita; Yvon Calmus; Filomena Conti
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

8.  Alternate reading frame protein (F protein) of hepatitis C virus: paradoxical effects of activation and apoptosis on human dendritic cells lead to stimulation of T cells.

Authors:  Subodh Kumar Samrat; Wen Li; Shakti Singh; Rakesh Kumar; Babita Agrawal
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+.

Authors:  Agnieszka Pawełczyk; Natalia Kubisa; Joanna Jabłońska; Iwona Bukowska-Ośko; Kamile Caraballo Cortes; Maria Fic; Tomasz Laskus; Marek Radkowski
Journal:  Virol J       Date:  2013-11-26       Impact factor: 4.099

10.  Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids.

Authors:  Stephanie Pfaender; Fabian A Helfritz; Anindya Siddharta; Daniel Todt; Patrick Behrendt; Julia Heyden; Nina Riebesehl; Wiebke Willmann; Joerg Steinmann; Jan Münch; Sandra Ciesek; Eike Steinmann
Journal:  Front Microbiol       Date:  2018-03-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.